Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IQVIA Holdings Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
IQV
New York
2830
www.iqvia.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IQVIA Holdings Inc.
This Healthcare Services Stock Has 37% Upside
- Aug 13th, 2026 6:01 am
Amgen Stock And The Price Of A Promise
- Aug 12th, 2026 1:17 pm
IQV Stock Gains 42% in 3 Months: Here's What You Should Know
- Aug 12th, 2026 7:09 am
How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook
- Aug 9th, 2026 9:11 am
IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies
- Aug 6th, 2026 10:30 am
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
- Aug 6th, 2026 9:29 am
FISV Q2 Earnings Miss Estimates on Margin Pressure, Revenues Decline
- Aug 6th, 2026 9:19 am
Is MEDP Worth Buying as Growth Collides With a Premium Valuation?
- Aug 6th, 2026 8:47 am
[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Aug 5th, 2026 10:30 am
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
- Aug 5th, 2026 8:56 am
Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?
- Aug 5th, 2026 8:33 am
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
- Aug 4th, 2026 2:15 pm
Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists?
- Aug 4th, 2026 10:33 am
Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last
- Aug 4th, 2026 9:58 am
The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2
- Aug 4th, 2026 7:59 am
1 Surging Stock with Exciting Potential and 2 Facing Challenges
- Aug 4th, 2026 6:45 am
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know
- Aug 2nd, 2026 2:12 pm
Scroll